Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


CNSystems Medizintechnik AG receives FDA approval for CNAP Monitor 500


Graz, Austria, 10 November 2008- CNSystems Medizintechnik AG, a medical device company marketing CNAP™, today announced that the U.S. Food and Drug Administration has cleared the 510(k) notification for CNSystem's CNAP™ Monitor 500, permitting the sale of this product in the United States.

The CNAP™ Monitor 500 measures non-invasive and continuous blood pressure in real-time and can predict responsiveness to fluid administration. In the perioperative setting, detecting blood pressure drops and their cause in time is crucial for peri- and postoperative outcome. However, until recently only invasive methods provided quality information to the clinician. CNAP™ provides reliable blood pressure monitoring comparable to invasive techniques and adds valuable information about fluid responsiveness of the patient non-invasively. This allows spreading the highest level of blood pressure monitoring to all perioperative settings where close blood pressure monitoring is indicated, but the risk and discomfort of invasive measurement is not justified.

“CNAP™ is very well received amongst Europe’s anesthesiologists in only a short time,” commented Dr. Juergen Fortin, CEO of CNSystems, “and we are confident that the same will be true in the USA where the perioperative market for continuous non-invasive blood pressure control is even more promising, with an estimated sales potential of € 150 million per year (approx. $190 million p.a.).”

Images of the CNAP™ Monitor 500 can be downloaded at the following link:
http://www.cnsystems.at/fileadmin/user_upload/_temp_/PA_Material.zip

- ends -

About CNAP™ and CNSystems Medizintechnik AG

CNSystems markets CNAP™, the first continuous, non-invasive blood pressure management system ready for day-to-day clinical use. CNAP™ offers clinicians an easy-to-use and efficient way to measure the blood pressure and control the fluid state without discomfort to the patient. The system is appropriate to the majority of patients in perioperative settings where close blood pressure monitoring is indicated but the risk and discomfort of invasive measurement is not justified. CNSystems offers CNAP™ directly to clinicians as CNAP™ Monitor 500, which is compatible with the leading patient monitoring systems on the market. CNAP™ is also available as module and can be integrated within other monitoring systems by medical device manufacturers. CNSystems is a private company located in Graz, Austria. Further information on CNSystems can be found at www.cnsystems.at .

Further Information:

Christopher Arbeiter
Head of Sales & Marketing
CNSystems Medizintechnik AG
t : +43 (0) 316 7234560
e : office@cnsystems.at

Douglas Pretsell
Account Director, Munich Bureau Chief
College Hill Life Sciences
t : +49 (0)89 57 00 18 06
e : douglas.pretsell@collegehill.com


Publisher Contact Information:

CNSystems Medizintechnik
+43 (0) 316 7234560
office@cnsystems.at

Company profile of CNSystems Medizintechnik
Past press releases of CNSystems Medizintechnik.

Data


26,416
Tech investments
From our Online Data Service
17,054
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Nov 30€3.6MSoftware development
Nov 29€3.6MBiopharmaceuticals
Nov 28N/ABiotechnology
Nov 28N/ABusiness applications
Nov 28€12.0MPublishing
Nov 28N/AeLearning
Nov 28€7.6MSensors

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.